Is decreased libido associated with the use of HMG-CoA-reductase inhibitors?
- PMID: 15327593
- PMCID: PMC1884568
- DOI: 10.1111/j.1365-2125.2004.02128.x
Is decreased libido associated with the use of HMG-CoA-reductase inhibitors?
Abstract
Aims and methods: To describe patients with decreased libido during use of a HMG-CoA-reductase-inhibitor, and to discuss causality and pharmacological hypotheses for this association by analysis of the adverse drug reactions (ADR) database of the Netherlands Pharmacovigilance Centre Lareb.
Results: Eight patients were identified as having decreased libido during use of statins. In two of these cases testosterone levels were determined and appeared to be decreased.
Conclusion: Decreased libido is a probable adverse drug reaction of HMG-CoA-reductase-inhibitors and is reversible. The ADR may be caused by low serum testosterone levels, mainly due to intracellular cholesterol depletion.
References
-
- Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract. 2002;19:95–8. - PubMed
-
- Crenshaw TL, Goldberg PJ. Testosterone in men. In: Crenshaw TL, Goldberg PJ, editors. Sexual Pharmacology. New York: WW Norton Co.; 1996. pp. 115–28.
-
- Griffin JE, Wilson JD. Disorders of the testes. In: Braunwald E, Fauci AS, Kapser DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 15. New York: McGraw-Hill Medical Publishing Division; 2001. pp. 2143–54.
-
- Ginsberg HN, Golberg IJ. Disorders of intermediary metabolism. In: Braunwald E, Fauci AS, Kapser DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 15. New York: McGraw-Hill Medical Publishing Division; 2001. pp. 2245–57.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
